{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:28:57Z","timestamp":1790620137130,"version":"4.1.0"},"reference-count":69,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Endometriosis is a chronic, multifactorial, estrogen-dependent disease. The abnormal endocrine microenvironment of endometriosis lesions is considered a main feature and multiple enzymatic pathways leading to local increased synthesis of estrogens have been identified. However, the relevance of intracrinology in clinical practice is still lacking. Medline, Embase, Scopus database were systematically searched for studies reporting on local estrogens metabolism of endometriotic lesions. The main enzymatic pathways involved in the intracrinology of endometriosis such as aromatase (CYP19A1), 17\u03b2-hydroxysteroid dehydrogenase (HSD17B) type 1, type 2 and type 5, steroid sulfatase (STS), estrogen sulfotransferase (SULT1E1) were assessed with a critical perspective on their role in disease endocrine phenotyping, drug resistance and as therapeutic targets. Overall, studies heterogeneity and missing clinical data affect the interpretation of the clinical role of these enzymes. Although the use of some drugs such as aromatase inhibitors has been proposed in clinical practice for two decades, their potential clinical value is still under investigation as well as their modality of administration. A closer look at new, more realistic drug targets is provided and discussed. Altered expression of these key enzymes in the lesions have far reaching implication in the development of new drugs aimed at decreasing local estrogenic activity with a minimal effect on gonadal function; however, given the complexity of the evaluation of the expression of the enzymes, multiple aspects still remains to be clarified.<\/jats:p><jats:sec><jats:title>Systematic Review Registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?ID=CRD42022311329<\/jats:uri>, identifier CRD42022311329.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.950866","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T10:31:22Z","timestamp":1663669882000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Is intracrinology of endometriosis relevant in clinical practice? A systematic review on estrogen metabolism"],"prefix":"10.3389","volume":"13","author":[{"given":"Antonio","family":"Mercorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Giampaolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"D\u00e4llenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Pluchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.680833","article-title":"Environmental risk factors for endometriosis: An umbrella review of a meta-analysis of 354 observational studies with over 5 million populations","volume":"8","author":"Zhang","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-018-0008-5","article-title":"Endometriosis","volume":"4","author":"Zondervan","year":"2018","journal-title":"Nat Rev Dis Primers."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2013.255","article-title":"Endometriosis: pathogenesis and treatment","volume":"10","author":"Vercellini","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21082815","article-title":"Estrogen receptors and endometriosis","volume":"21","author":"Chantalat","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804690","article-title":"Endometriosis","volume":"360","author":"Bulun","year":"2009","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.01.036","article-title":"Estrogen receptor-\u03b1 immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis","volume":"113","author":"Pluchino","year":"2020","journal-title":"Fertil Steril."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaa249","article-title":"Superficial peritoneal endometriotic lesions are histologically diverse and rarely demonstrate menstrual cycle synchronicity with matched eutopic endometrium","volume":"35","author":"Colgrave","year":"2020","journal-title":"Hum Reprod"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2014.04.012","article-title":"Neurobiology of DHEA and effects on sexuality, mood and cognition","volume":"145","author":"Pluchino","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/GME.0000000000001177","article-title":"Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues","volume":"26","author":"Labrie","year":"2019","journal-title":"Menopause (New York NY)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3276","DOI":"10.3390\/ijms19103276","article-title":"Endometrial intracrinology: Oestrogens, androgens and endometrial disorders","volume":"19","author":"L Gibson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.mce.2018.10.004","article-title":"Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review","volume":"489","author":"Cornel","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.00940","article-title":"Intracrine regulation of estrogen and other sex steroid levels in endometrium and non-gynecological tissues; pathology, physiology, and drug discovery","volume":"9","author":"Konings","year":"2018","journal-title":"Front Pharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.82.2.3783","article-title":"Bulun, prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells","volume":"82","author":"Noble","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/jc.82.2.600","article-title":"Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells","volume":"82","author":"Noble","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/humupd\/dmi034","article-title":"Aromatase and other steroidogenic genes in endometriosis: translational aspects","volume":"12","author":"Attar","year":"2006","journal-title":"Hum Reprod"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-020-0258-4","article-title":"mRNAs, proteins and the emerging principles of gene expression control","volume":"21","author":"Buccitelli","year":"2020","journal-title":"Nat Rev Genet"},{"key":"B18","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1177\/1933719107309120","article-title":"Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis","volume":"14","author":"Hudelist","year":"2007","journal-title":"Reprod Sci"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2006.11.188","article-title":"Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings","volume":"88","author":"Aci\u00e9n","year":"2007","journal-title":"Fertil Steril"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep199","article-title":"Absence of aromatase protein and mRNA expression in endometriosis","volume":"24","author":"Colette","year":"2009","journal-title":"Hum Reprod"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S29154","article-title":"Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis","volume":"4","author":"Maia","year":"2012","journal-title":"Int J Womens Health"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab258","article-title":"Peritoneal fluid progesterone and progesterone resistance in superficial endometriosis lesions","volume":"37","author":"Koninckx","year":"2022","journal-title":"Hum Reprod"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2218","article-title":"Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism","volume":"94","author":"Delvoux","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00022-3","article-title":"Treatment of severe postmenopausal endometriosis with an aromatase inhibitor","volume":"69","author":"Takayama","year":"1998","journal-title":"Fertil Steril."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.08.053","article-title":"Aromatase inhibitors for the treat- ment of endometriosis [Review]","volume":"98","author":"Pavone","year":"2012","journal-title":"Fertil Steril."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh035","article-title":"Gezgin T: The effects of post-surgicaladministration of goserelin plus anastrozole compared to goserelin alone in patients with severe endometriosis: a prospective randomized trial","volume":"19","author":"Soysal","year":"2004","journal-title":"Hum Reprod"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep302","article-title":"Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis","volume":"24","author":"Ferrero","year":"2009","journal-title":"Hum Reprod"},{"key":"B28","first-page":"67","article-title":"Effects of letrozole compared with danazol on patients with confirmed endometriosis: A randomized clinical trial","volume":"4","author":"Roghaei","year":"2010","journal-title":"IJFS"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-010-1599-6","article-title":"A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis","volume":"284","author":"Alborzi","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1477-7827-9-88","article-title":"Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial","volume":"9","author":"Ferrero","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2581-2","article-title":"Changes in the size of rectovaginal endometriotic nodules infiltrating the rectum during hormonal therapies","volume":"287","author":"Ferrero","year":"2013","journal-title":"Arch Gynecol Obstet."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2013.11.030","article-title":"Norethisterone acetate versus norethisterone acetatecombined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study","volume":"174","author":"Ferrero","year":"2014","journal-title":"Eur JObstet Gynecol Reprod Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det457","article-title":"European Society of human reproduction and embryology. ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman","year":"2014","journal-title":"Hum Reprod"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2004.11.034","article-title":"The vagina as a route for systemic drug delivery","volume":"103","author":"Hussain","year":"2005","journal-title":"J\u00a0Control Release"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew145","article-title":"Pharmacokinetics, pharmacodynamics, safety and tolerability of an intravaginal ring releasing anastrozole and levonorgestrel in healthy premenopausal women: a phase 1 randomized controlled trial","volume":"31","author":"Schultze-Mosgau","year":"2016","journal-title":"Hum Reprod"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1396","article-title":"Absence of drug-drug-interaction of anastrozole on levonorgestrel delivered simultaneously by an intravaginal ring: results of a phase 2 trial","volume":"59","author":"Nave","year":"2019","journal-title":"J Clin Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.04.059","article-title":"Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study","volume":"84","author":"Hefler","year":"2005","journal-title":"Fertil Steril."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.14372","article-title":"Effect of local aromatase inhibition in endometriosis using a new chick embryo chorioallantoic membrane model","volume":"23","author":"Pluchino","year":"2019","journal-title":"J Cell Mol Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.12.4474","article-title":"Deficient 17-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17-estradiol","volume":"83","author":"Zeitoun","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2005.08.017","article-title":"Analysis of aro-matase and 17-hydroxysteroid dehydroganse type 2 messenger ribonucleicacid expression in deep endometriosis and eutopic endometrium using lasercapture microdissection","volume":"85","author":"Matsuzaki","year":"2006","journal-title":"Fertil Steril"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem310","article-title":"Estrogen metabolizingenzymes in endometrium and endometriosis","volume":"22","author":"Dassen","year":"2007","journal-title":"Hum Reprod"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1080\/09513590601152219","article-title":"Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis","volume":"23","author":"Smuc","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mce.2008.07.020","article-title":"Disturbed estrogen and progesterone action in ovarian endometriosis","volume":"301","author":"Smuc","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-1154","article-title":"Endometrial and endometriotic concentrations of estrone and estradiol are determined by local metabolism rather than circulating levels","volume":"97","author":"Huhtinen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.08.003","article-title":"Differential expression of steroidogenic enzymes according to endometriosis type","volume":"100","author":"Colette","year":"2013","journal-title":"Fertil Steril."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-2851","article-title":"Inhibition of type 1 17beta-hydroxysteroid dehydrogenase impairs the synthesis of 17beta-estradiol in endometriosis lesions","volume":"99","author":"Delvoux","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2014.11.009","article-title":"Expression of AKR1B1, AKR1C3 and other genes of prostaglandin F2\u03b1 biosynthesis and action in ovarian endometriosis tissue and in model cell lines, chem","volume":"234","author":"Sinreih","year":"2015","journal-title":"Biol Interact"},{"key":"B48","doi-asserted-by":"publisher","first-page":"104446","DOI":"10.1016\/j.phrs.2019.104446","article-title":"Aldo-keto reductase 1C3-assessment as a new target for the treatment of endometriosis","volume":"152","author":"Ri\u017ener","year":"2020","journal-title":"Pharmacol Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.mce.2005.10.024","article-title":"Deoxycorticosterone inactivation by AKR1C3 in human mineralocorticoid target tissues, mol","volume":"248","author":"Sharma","year":"2006","journal-title":"Cell Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.08.016","article-title":"Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis, fertil","volume":"100","author":"Rakhila","year":"2013","journal-title":"Steril"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2011.01.003","article-title":"Aldo-keto reductases AKR1C1, AKR1C2 and AKR1C3 may enhance progesterone metabolism in ovarian endometriosis, chem","volume":"191","author":"Hevir","year":"2011","journal-title":"Biol Interact"},{"key":"B52","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jsbmb.2010.12.007","article-title":"Contribution to the development of inhibitors of 17\u03b2-hydroxysteroid dehydrogenase types 1 and 7: key tools for studying and treating estrogen-dependent diseases","volume":"125","author":"Poirier","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0042","article-title":"Design and validation of specific inhibitors of 17-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis","volume":"15","author":"Day","year":"2008","journal-title":"Endocr Relat Cancer."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dem308","article-title":"Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy","volume":"23","author":"Purohit","year":"2008","journal-title":"Hum Reprod"},{"key":"B55","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2012.12.019","article-title":"Disturbed balance between phase I and II metabolizing enzymes in ovarian endometriosis: a source of excessive hydroxy-estrogens and ROS","volume":"367","author":"Hevir","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsbmb.2015.12.025","article-title":"Effects of steroid hormone on estrogen sulfotransferase and on steroid sulfatase expression in endometriosis tissue and stromal cells","volume":"158","author":"Piccinato","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/der079","article-title":"Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model","volume":"26","author":"Colette","year":"2011","journal-title":"Hum Reprod"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114522526","article-title":"Synergistic effects of E2MATE and norethindrone acetate on steroid sulfatase inhibition: a randomized phase I proof-of-principle clinical study in women of reproductive age","volume":"21","author":"Pohl","year":"2014","journal-title":"Reprod Sci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00062","article-title":"First dual inhibitors of steroid sulfatase (STS) and 17\u03b2-hydroxysteroid dehydrogenase type 1 (17\u03b2-HSD1): Designed multiple ligands as novel potential therapeutics for estrogen-dependent diseases","volume":"60","author":"Salah","year":"2017","journal-title":"J Med Chem"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.05.004","article-title":"Reevaluating response and failure of medical treatment of endometriosis: a systematic review","volume":"108","author":"Becker","year":"2017","journal-title":"Fertility Sterility"},{"key":"B61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/humupd\/dmi034","article-title":"Aromatase and other steroidogenic genes in endometriosis: translational aspects","volume":"12","author":"Attar","year":"2006","journal-title":"Hum Reprod"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.11.005","article-title":"Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E2 productionin human endometriotic stromal cells in spheroid culture","volume":"97","author":"Yamanaka","year":"2012","journal-title":"Fertility Sterility"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2010.08.010","article-title":"Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system","volume":"76","author":"Shimizu","year":"2011","journal-title":"Steroids"},{"key":"B64","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1530\/JOE-15-0052","article-title":"Dienogest reduces HSD17beta1 expression and activity in endometriosis","volume":"225","author":"Mori","year":"2015","journal-title":"J Endocrinol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep437","article-title":"Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy","volume":"25","author":"Khan","year":"2010","journal-title":"Hum Reprod"},{"key":"B66","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12894-017-0261-z","article-title":"A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients","volume":"17","author":"Miyazawa","year":"2017","journal-title":"BMC Urol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","author":"Ishihara","year":"2003","journal-title":"Fertil Steril"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2003.12.044","article-title":"Gonadotropin-releasing hormone agonist inhibits estrone sulfatase expression of cystic endometriosis in the ovary","volume":"82","author":"Maitoko","year":"2004","journal-title":"Fertil Steril."},{"key":"B69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1056\/NEJMoa1700089","article-title":"Treatment of endometriosis-associated pain with elagolix, an oral GnRH antagonist","volume":"377","author":"Taylor","year":"2017","journal-title":"New Engl J Med"}],"updated-by":[{"DOI":"10.3389\/fendo.2023.1177346","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.950866\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T09:47:01Z","timestamp":1678441621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.950866\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":69,"alternative-id":["10.3389\/fendo.2022.950866"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.950866","relation":{"erratum":[{"id-type":"doi","id":"10.3389\/fendo.2023.1177346","asserted-by":"object"}]},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"950866"}}